Brief: Charles River Laboratories International Inc - Dsa Net Book-To-Bill Improved Each Month Since Q3 2025 - SEC Filing
Dec 3 (Reuters) - Charles River Laboratories International Inc CRL.N: CHARLES RIVER LABORATORIES INTERNATIONAL INC - DSA NET BOOK-TO-BILL IMPROVED EACH MONTH SINCE Q3 2025 - SEC FILING CHARLES RIVER LABORATORIES INTERNATIONAL- SEASONALITY DURING HOLIDAY PERIODS IN Q4 AND IN EARLY JAN MAY IMPACT NEAR-TERM PROPOSAL, BOOKING ACTIVITY Source text: [ID:n0001628280-25-054902] Further company coverage: CRL.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charles River Laboratories International
See all newsBrief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
European life sciences stocks rise on strong sector momentum